InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Taubert Jennifer L, Directrice Exécutive. Officer active across 1 companies, notably Johnson & Johnson. Aggregated, 3 disclosures have been logged. The latest transaction was filed on 15 February 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
018,064 shares0
Common Stock
SEC:0001225208-22-002377:0·
018,064 shares0
Common Stock
SEC:0001225208-22-002377·
03,297 shares0
Common Stock
SEC:0001225208-22-002211:0·
3 of 3 declarations
About Taubert Jennifer L
Jennifer L. Taubert serves as Executive Vice President and Worldwide Chair of Pharmaceuticals at Johnson & Johnson. She oversees global operations and strategies for pharmaceutical product development. Jennifer plays a key role in innovation and continuous improvement of the company's products.
